International Clinical Trial: Predictive Value of Maternal Immune Inflammatory Markers in Late Pregnancy for Neonatal Acute Respiratory Distress Syndrome Based on Machine Learning Algorithms

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133593) titled 'Predictive Value of Maternal Immune Inflammatory Markers in Late Pregnancy for Neonatal Acute Respiratory Distress Syndrome Based on Machine Learning Algorithms' on Sept. 29.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The first hospital of Shanxi Medical University

Condition: Neonatal Acute Respiratory Distress Syndrome

Intervention: NARDS Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: NARDS Group:120;ARDS Group:107;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn...